Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Involved Node Radiotherapy in Stage IIA/B Seminoma
NCT01593241Phase 2Terminated
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jun 2012
- Primary completion
- Jan 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of carboplatin in seminoma, sponsored by Swiss Group for Clinical Cancer Research. Started Jun 2012; status: terminated.
02
Drugs
carboplatin
03
Conditions
seminoma
Beyond the preview
Go deeper on NCT01593241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01593241.